Cigna Group (NYSE:CI) Price Target Cut to $370.00 by Analysts at Piper Sandler

Cigna Group (NYSE:CI) had its price target cut by Piper Sandler from $374.00 to $370.00 in a report published on Tuesday, MarketBeat reports. They currently have an overweight rating on the health services provider’s stock.

CI has been the topic of several other reports. Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $307.00 price objective on shares of Cigna Group in a research note on Tuesday, January 6th. UBS Group reissued a “buy” rating and set a $375.00 target price on shares of Cigna Group in a research note on Monday, February 9th. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Finally, Guggenheim reaffirmed a “buy” rating and issued a $318.00 price target on shares of Cigna Group in a report on Monday, February 2nd. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $330.42.

Cigna Group Price Performance

NYSE CI opened at $283.58 on Tuesday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The firm has a market capitalization of $74.73 billion, a PE ratio of 12.79, a P/E/G ratio of 1.01 and a beta of 0.27. The company’s 50 day simple moving average is $280.48 and its 200 day simple moving average is $284.45. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The firm had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. During the same period last year, the company posted $6.64 EPS. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, equities research analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be given a $1.56 dividend. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date is Thursday, March 5th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s payout ratio is currently 27.23%.

Insider Activity at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Everett Neville sold 1,719 shares of the stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the sale, the insider owned 5,670 shares of the company’s stock, valued at $1,638,119.70. The trade was a 23.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Cigna Group

Large investors have recently made changes to their positions in the business. Wilkerson Advisory Group LLC acquired a new position in Cigna Group in the 4th quarter valued at approximately $25,000. Harbor Capital Advisors Inc. grew its holdings in shares of Cigna Group by 119.5% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after acquiring an additional 49 shares in the last quarter. Beacon Financial Strategies CORP acquired a new position in shares of Cigna Group in the fourth quarter worth $28,000. Kemnay Advisory Services Inc. acquired a new stake in shares of Cigna Group in the 4th quarter valued at $29,000. Finally, Prosperity Bancshares Inc acquired a new stake in Cigna Group in the 4th quarter worth approximately $29,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

More Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Piper Sandler kept an Overweight rating on CI and cut its price target slightly to $370 (from $374), implying roughly 30% upside from current levels — a vote of confidence from an institutional analyst. Piper Sandler price target story
• Positive Sentiment: Cigna reaffirmed its 2026 financial outlook while announcing the succession plan and said Brian Evanko was elected to the board — the reaffirmation reduces immediate earnings guidance risk. PR Newswire release
• Positive Sentiment: Analyst/strategy pieces (e.g., Zacks) continue to highlight Cigna’s growth characteristics and strong fundamentals after recent results, supporting a longer-term constructive view. Zacks analysis
• Neutral Sentiment: Cigna executives (CFO Ann Dennison and Evernorth president Adam Kautzner) presented at the TD Cowen healthcare conference this week — useful for investor Q&A but not a major catalyst. TD Cowen presentation notice
• Neutral Sentiment: Corporate/regional PR (e.g., broker awards in Dubai) highlights distribution/partner relationships but is unlikely to move the stock materially. BusinessWire awards story
• Negative Sentiment: The market reacted negatively to the announced CEO succession: long-time CEO David Cordani will retire July 1, 2026 and become executive chair while President/COO Brian Evanko becomes CEO. Coverage flagged investor concern about leadership change despite Evanko being an internal choice; that concern appears to be the primary near-term reason for the stock decline. Seeking Alpha on leadership transition

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.